Ruxolitinib phosphate: JAK/STAT Workflow Guide

2026-08-24

Build reproducible JAK1/JAK2 inhibition assays for cytokine biology, autoimmune disease models, and anaplastic thyroid cancer research. This guide connects practical dosing and troubleshooting with evidence that links STAT3 suppression to mitochondrial remodeling, apoptosis, and GSDME-associated pyroptosis.

From PS Exposure to Mechanism in Ph+ ALL

2026-08-24

A translational framework for using Annexin V-Cy5/DAPI staining to connect P2RX1-driven mitochondrial apoptosis with actionable cell-death measurements in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Naftifine HCl for Reproducible Cell Assays

2026-08-23

A scenario-based guide to using Naftifine HCl in fungal and mammalian cell viability, proliferation, and cytotoxicity workflows. It explains solvent controls, assay-interference checks, protocol parameters, interpretation limits, and why SKU B1984 is a practical research-grade option.

TG003: A Cdc2-like Kinase Inhibitor Workflow

2026-08-22

TG003 enables reversible interrogation of Clk-dependent phosphorylation, alternative splicing, and platinum-resistance biology in one adaptable workflow. Its strongest use is not as a single-target drug surrogate, but as a dose-controlled mechanistic probe paired with isoform-aware RNA assays, kinase readouts, and genetic controls.

Dabigatran: From Thrombin Target to Assay Signal

2026-08-22

Dabigatran and Pradaxa provide a mechanistically defined route to thrombin inhibition. This guide connects molecular pharmacology, assay endpoint selection, physicochemical constraints, and translational interpretation for more reliable coagulation research.

Anti Reverse Cap Analog for High-Expression mRNA

2026-08-21

Learn how orientation-specific capping with ARCA improves synthetic mRNA translation workflows, from reaction setup and quality control to troubleshooting low protein output. The guide also translates insights from a targeted mRNA nanoparticle study into practical assay choices for mRNA therapeutics research without assuming that ARCA was used in the published work.

v-Agatoxin-IVA and Neuronal N-Type Ca Channels

2026-08-20

Eucommia Leaf Extract Improves Pig Meat Quality

2026-08-20

Wang and colleagues evaluated Eucommia ulmoides leaf extract in finishing pigs using an integrated design that combined antioxidant, meat-quality, muscle-gene, and cecal-microbiota measurements. The study found that extract supplementation, particularly at 0.050%, improved oxidative status and selected pork-quality traits without increasing growth performance, while microbiota changes were associated with health and meat-quality indicators.

Gastrin I: Designing Better GI Organoid Assays

2026-08-19

Gastrin I enables controlled studies of CCK2 receptor signaling, proton pump activation, and gastric acid secretion. This article explains how to select compatible human organoid models and avoid overinterpreting intestinal pharmacokinetic platforms.

Primidone: An Evidence-Calibrated Research Guide

2026-08-19

Primidone, also known as Mysoline, is more than a conventional antiepileptic scaffold. This evidence-calibrated guide connects its TRPM3 and RIPK1 pharmacology with rigorous assay design, translational dosing, and lessons from antimicrobial biofilm research without overstating cross-domain evidence.

HyperScribe T7 High Yield Cy3 RNA Labeling Kit Guide

2026-08-18

Build bright, customizable RNA probes for in situ hybridization and Northern blot workflows with tunable Cy3-UTP incorporation. This practical guide connects probe design and troubleshooting to the MALAT1/miR-125b/STAT3 sepsis study while distinguishing published findings from workflow recommendations.

Nifedipine Research Workflows: Calcium & PXR

2026-08-18

Nifedipine (BAY-a-1040) provides a controllable L-type calcium influx perturbation for cardiac, iron-transport, hepatic, and pathogen assays. This guide translates the reference study’s PXR and CYP findings into practical comparison workflows while clearly separating calcium-channel effects from direct nuclear-receptor activation.

SmD2 Acetylation Links Splicing to PARP Sensitivity

2026-08-17

A 2024 Nature Communications study identifies the spliceosomal protein SmD2 as an acetylation-regulated determinant of BRCA1/FANC cassette-exon expression and PARP inhibitor sensitivity in hepatocellular carcinoma. The findings connect core spliceosome regulation with DNA damage repair and support combining HDAC inhibition with PARP inhibition in selected HCC models.

IWP-2 Workflows for Wnt Production Inhibition

2026-08-17

IWP-2 enables upstream Porcn blockade for studying Wnt-dependent proliferation, invasion, and apoptosis in gastric cancer models. This practical guide also shows how to adapt the inhibitor into cell-type-resolved developmental assays without overstating evidence from neurodevelopmental research.

LDN-193189: Mapping BMP Signals in Cell Plasticity

2026-08-16

Explore how LDN-193189, a selective ALK inhibitor, can separate BMP receptor signaling from TGF-β-driven epithelial plasticity. This article translates mechanistic evidence into assay strategies for stem-cell, barrier, and heterotopic ossification research.